Walleye Capital Portfolio holdings
AUM
$10.8B
1-Year Return
8.39%
This Quarter Return
+8.69%
1 Year Return
+8.39%
3 Year Return
+34.69%
5 Year Return
+89.54%
10 Year Return
–
AUM
$4.6B
AUM Growth
+$207M
(+4.7%)
Cap. Flow
-$305M
Cap. Flow
% of AUM
-6.63%
Top 10 Holdings %
Top 10 Hldgs %
9.73%
Holding
3,109
New
619
Increased
481
Reduced
343
Closed
772
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$97.8M |
| 2 |
SPDR S&P Retail ETF
XRT
|
$43.9M |
| 3 |
Johnson Controls International
JCI
|
$30.4M |
| 4 |
Sun Communities
SUI
|
$30.3M |
| 5 |
Allegion
ALLE
|
$30M |
Top Sells
Sector Composition
| 1 | Financials | 15.67% |
| 2 | Industrials | 14.07% |
| 3 | Healthcare | 10.83% |
| 4 | Consumer Discretionary | 8.87% |
| 5 | Technology | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Consumers Staples Select Sector SPDR Fund
XLP
$15.7B
| $3.42M | 0.06% |
45,906
-212,199
| -82% | -$15.8M |
|
302
Apple Hospitality REIT
APLE
$3.06B
| $3.41M | 0.06% |
+216,267
| New | +$3.41M |
|
303
Xenon Pharmaceuticals
XENE
$2.96B
| $3.41M | 0.06% |
86,517
-1,454
| -2% | -$57.3K |
|
304
CF Industries
CF
$13.7B
| $3.4M | 0.06% |
39,940
+10,213
| +34% | +$870K |
|
305
Alaska Air
ALK
$7.37B
| $3.4M | 0.06% |
+79,146
| New | +$3.4M |
|
306
Berkshire Hathaway Class B
BRK.B
$1.07T
| $3.38M | 0.06% |
10,933
+4,167
| +62% | +$1.29M |
|
|
NHIC
307
DELISTED
NewHold Investment Corp. II Class A Common Stock
NHIC
| $3.37M | 0.06% |
+338,803
| New | +$3.37M |
|
308
Teradata
TDC
$2.01B
| $3.35M | 0.06% |
+99,497
| New | +$3.35M |
|
|
MRNS
309
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $3.35M | 0.06% |
840,757
+554,074
| +193% | +$2.21M |
|
310
Buckle
BKE
$3.05B
| $3.34M | 0.06% |
+73,669
| New | +$3.34M |
|
311
Thomson Reuters
TRI
$77.9B
| $3.33M | 0.06% |
+28,142
| New | +$3.33M |
|
312
Intellia Therapeutics
NTLA
$1.29B
| $3.33M | 0.06% |
95,424
+77,163
| +423% | +$2.69M |
|
313
Wyndham Hotels & Resorts
WH
$6.68B
| $3.31M | 0.06% |
46,382
-45,402
| -49% | -$3.24M |
|
|
INVX
314
Innovex International, Inc.
INVX
$1.13B
| $3.3M | 0.06% |
+121,403
| New | +$3.3M |
|
|
SABRP
315
DELISTED
Sabre Corporation 6.50% Series A Mandatory Convertible Preferred Stock
SABRP
| $3.28M | 0.06% |
38,937
| – | – |
|
316
Geron
GERN
$880M
| $3.2M | 0.06% |
1,323,378
+309,449
| +31% | +$749K |
|
|
GLOP
317
DELISTED
GASLOG PARTNERS LP
GLOP
| $3.2M | 0.06% |
480,613
+203,582
| +73% | +$1.36M |
|
318
L3Harris
LHX
$51.3B
| $3.2M | 0.06% |
+15,350
| New | +$3.2M |
|
319
Natera
NTRA
$23B
| $3.17M | 0.06% |
78,796
+72,686
| +1,190% | +$2.92M |
|
|
NOVA
320
DELISTED
Sunnova Energy
NOVA
| $3.15M | 0.06% |
175,076
+76,636
| +78% | +$1.38M |
|
|
ADER
321
DELISTED
26 Capital Acquisition Corp. Class A Common Stock
ADER
| $3.15M | 0.06% |
310,982
+256,000
| +466% | +$2.59M |
|
322
Consolidated Edison
ED
$34.9B
| $3.15M | 0.06% |
33,049
-26,983
| -45% | -$2.57M |
|
323
Essential Properties Realty Trust
EPRT
$6.02B
| $3.13M | 0.06% |
133,437
+18,535
| +16% | +$435K |
|
324
Public Service Enterprise Group
PEG
$40B
| $3.1M | 0.06% |
50,563
-2,309
| -4% | -$141K |
|
|
CBAY
325
DELISTED
Cymabay Therapeutics
CBAY
| $3.07M | 0.06% |
488,894
+268,903
| +122% | +$1.69M |
|